Thus, cytogenetically normal (CN) young patients with high ID1 expression have lower complete remission (CR) rates, and worse OS and DFS, suggesting that ID1-negative patients should be classified as unfavorable-risk leukemia [18, 59–61]. This evidence concerns the gene ID1 and leukemia.